Model N
Overview
Leading revenue optimization and compliance software platform for pharmaceutical and medtech manufacturers, managing pricing, contracting, rebates, chargebacks, government pricing, and gross-to-net analytics. The platform manages over $1.3 trillion in gross revenue for life sciences and high-tech innovators.
Notable
Taken private by Vista Equity Partners in June 2024 for ~$1.25B; acquired drug discount analytics platform Kalderos in June 2026 to add claims-level 340B and GTN visibility.
Key services
- revenue management software
- pricing and contracting
- rebate and chargeback administration
- government pricing compliance
- gross-to-net analytics
- 340B discount management
Subcategories
Verified Reviews
No verified reviews yet — are you a customer of Model N? Share your experience in a short, confidential interview.
Share your experience